Crossref
HER2-overexpressed metastatic colorectal cancer: Towards personalized treatment?
Hépato-Gastro & Oncologie Digestive · 2026-06 · 33 (6) · 654-662
DOI: 10.1684/hpg.2026.3184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hépato-Gastro & Oncologie Digestive, 2026-06. Verfasst von Marie Muller und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Muller, M., Trihan, C., & Lièvre, A. (2026). HER2-overexpressed metastatic colorectal cancer: Towards personalized treatment?. Hépato-Gastro & Oncologie Digestive, 33(6), 654-662. https://doi.org/10.1684/hpg.2026.3184
Vancouver
Muller M, Trihan C, Lièvre A. HER2-overexpressed metastatic colorectal cancer: Towards personalized treatment?. Hépato-Gastro & Oncologie Digestive. 2026;33(6):654-662. doi:10.1684/hpg.2026.3184
BibTeX
@article{Muller2026,
author = {Muller, Marie and Trihan, Clémence and Lièvre, Astrid},
title = {HER2-overexpressed metastatic colorectal cancer: Towards personalized treatment?},
journal = {Hépato-Gastro & Oncologie Digestive},
year = {2026},
volume = {33},
number = {6},
pages = {654--662},
doi = {10.1684/hpg.2026.3184}
}
EUVIMED